Are Peptides Legal? A Practical Guide

If you are researching peptide therapy, one of the first questions worth answering is a legal one: can you actually obtain these compounds lawfully, and under what conditions?

The answer is more specific than most online discussions suggest. Many peptides are legal when prescribed by a licensed clinician and dispensed through a licensed compounding pharmacy. The same compounds sold online as "research use only" products are not legal for human use. Legality depends almost entirely on the source, the prescription, and the regulatory status of the compound itself.

This guide explains how peptide legality works in plain terms, what the FDA's category system means, and how to evaluate a provider before you proceed.

Quick Answer: When Peptides Are Legal

The Federal Food, Drug, and Cosmetic Act

The Federal Food, Drug, and Cosmetic Act (FD&C Act) sets the foundation for how peptides are regulated. Under the FD&C Act, a "drug" includes any article intended to diagnose, treat, cure, or prevent disease — or to affect the structure or function of the body.

That definition matters. When a peptide is used therapeutically, it meets the legal definition of a drug, not a dietary supplement. This is why you cannot buy therapeutic peptides off a supplement shelf, and why legitimate access runs through prescribers and pharmacies. You can review the FD&C Act directly on FDA.gov.

FDA Regulation, FDA Approval, and FDA-Approved Peptides

FDA approval is a high bar. To approve a drug, the FDA requires extensive clinical trial data demonstrating that a specific compound is safe and effective for a specific use at a specific dose. That process takes years.

An "FDA-approved peptide" is one that has cleared this pathway for a defined clinical indication. Several peptide medications are FDA-approved. Many peptides used in compounded therapy are not approved as finished drugs but may still be lawfully prescribed and compounded, depending on their regulatory status.

Off-label prescribing — where a provider prescribes an approved drug for a use outside its labeled indication — remains a legitimate clinical decision made by a licensed provider. It is common across medicine and is not, by itself, illegal.

The FDA Category System

The FDA maintains an interim policy for bulk drug substances used in compounding. This policy historically sorted substances into three groups:

• Category 1: Substances under evaluation that may continue to be used in compounding while review is ongoing.
• Category 2: Substances that raised significant safety concerns and were prohibited from use in compounding.
• Category 3: Substances nominated without sufficient supporting information.

In its final interim guidance, the FDA consolidated the list, leaving Category 1 as the operative framework for substances permitted in compounding. Substances placed in Category 2 remain prohibited from use in compounded preparations. For the authoritative source, see the FDA's interim bulk drug substances policy. These category decisions directly determine which peptides a compounding pharmacy may legally prepare.

FDA Peptide Reclassification

Starting in September 2023, the FDA designated 19 peptides as Category 2, removing them from legal compounding over concerns including insufficient safety data and impurity risks. That decision eliminated the regulated pathway for those compounds and — as acknowledged in subsequent policy discussions — accelerated demand toward the unregulated gray market those restrictions were intended to reduce.

If Reclassification Occurs

A move back to Category 1 is not the same as full FDA approval. Category 1 status would allow legal compounding under a prescription — it would not mean the compound had completed the clinical trials required for drug approval. Patients would still need medical supervision, a valid prescription, and a licensed dispensing source. The responsible approach is to monitor official FDA publications rather than rely on headlines or vendor marketing.

Compounding Pharmacies and Bulk Drug Substances

Compounding is the practice of preparing a customized medication for an individual patient. Two types of facilities do this legally:

• 503A pharmacies are traditional compounding pharmacies that prepare medications for specific patients based on individual prescriptions.
• 503B outsourcing facilities operate under stricter manufacturing standards and can produce larger batches, often for clinics and healthcare facilities.

Both rely on bulk drug substances — the active pharmaceutical ingredients used to compound a finished preparation. Whether a peptide can be legally compounded depends on whether its bulk substance is permitted under current FDA policy.

What Makes a Peptide Compoundable

For a peptide to be lawfully compounded, its active ingredient must be permitted under FDA policy and must come from an appropriately documented source. Reputable pharmacies require a Certificate of Analysis (COA) for the materials they use — a document that verifies the identity, purity, and quality of each lot. Lot-level, third-party testing is the expected standard, meaning each batch is independently verified rather than taken on the supplier's word alone.

When evaluating a peptide therapy provider, ask directly whether the pharmacy provides COAs for each compound and whether those are available to patients on request. A reputable clinic will not hesitate to answer.

Grey Market and Black Market Risks

The "research use only" label is the central legal problem with grey-market peptides. Vendors use it to sidestep the rules that govern medications intended for human use. Purchasing these products for personal use places the risk entirely on you — no prescriber, no pharmacy oversight, no legal protection.

A compound that is chemically identical to a prescribed peptide can still be unsafe if it was made, handled, or labeled improperly. Regulatory status and product quality are not the same question — but they are related. The compounding framework exists in part because those quality standards are real and consequential.

Sermorelin: A Named Clinical Example

Sermorelin is a clear example of a peptide used in legitimate, prescribed therapy. It is a growth hormone-releasing hormone (GHRH) analog that stimulates the body's own production of growth hormone rather than replacing it directly — working through natural pituitary signaling rather than exogenous hormone delivery.

Sermorelin has a documented clinical history and has been used under medical supervision for decades. Its mechanism of action — stimulating natural GH release through the pituitary — describes how it functions. That is not a promise of a specific outcome. Individual response varies, and whether sermorelin is appropriate for any specific patient is a decision to reach with a licensed clinician after reviewing health history and lab work.

Compounds that remain on the FDA's restricted list are not named here because their legal status for compounding is currently unsettled or prohibited. Naming them as available options would misrepresent the regulatory picture. Sermorelin is one of the protocols available through Body Balance Medical's peptide therapy program. For a detailed overview of the sermorelin protocol specifically, see the sermorelin therapy page.

How Body Balance Medical Approaches Peptide Therapy

The legal framework for peptide therapy is only as reliable as the provider operating within it. Certification, sourcing practices, and provider credentials are the practical signals that separate a legitimate clinic from one cutting corners.

Every protocol at Body Balance Medical begins with an in-person evaluation by a licensed clinician at the Summerlin clinic. Peptide therapy is prescribed by Mia LoPreiato, NP, a licensed nurse practitioner, and dispensed through licensed compounding pharmacies operating under the 503A framework. That structure — individual evaluation, valid prescription, licensed pharmacy — is what makes compounded peptide therapy legal.

Peptide therapy is often considered alongside hormone optimization, and the two are evaluated together when clinically appropriate. You can read more about Mia LoPreiato, NP on the team page.

Body Balance Medical is LegitScript-certified. LegitScript certification means the clinic has been independently verified to operate within applicable state and federal law — including licensing, sourcing, and compliance practices. It is the same certification required to advertise healthcare services on Google and Meta, and it is not self-reported.

Practical Steps for Patients in Las Vegas

If you are evaluating a peptide therapy provider, these steps will help you distinguish a legitimate clinic from a grey-market seller or an operation that cannot account for where its compounds come from.

1. Verify LegitScript certification before proceeding. It confirms the provider has been independently reviewed for legal and regulatory compliance — not self-certified.
2. Ask about pharmacy sourcing. Confirm whether the clinic uses a 503A or 503B licensed pharmacy. A provider who cannot or will not answer this question directly is a meaningful red flag.
3. Request a Certificate of Analysis. For each lot, confirm the compound has been independently tested for identity and purity. Reputable pharmacies maintain these records and can provide them.
4. Bring your medical records to the initial evaluation. A legitimate provider conducts an individual clinical assessment — they are not dispensing based on a checkbox questionnaire or a telehealth form.

Athletes and Anti-Doping Rules

Competitive athletes should be aware that some peptides — whether legally prescribed or not — are prohibited under anti-doping rules. WADA and USADA maintain independent prohibited substance lists that do not track FDA legal status. A compound that is lawfully prescribed may still result in a positive test under a sport's anti-doping program. Athletes should consult their sport's governing body or anti-doping organization before starting any peptide protocol.

Medically Reviewed By

Mia LoPreiato, NP

Biote-Certified Hormone & Longevity Nurse Practitioner · Body Balance Medical, Las Vegas, NV. Mia specializes in hormone optimization, peptide therapy, and medically supervised longevity protocols. All clinical content on this page has been reviewed for accuracy and consistency with current prescribing standards.